WHO confirms the trial of anti-Malaria drug Hydroxychloroquine

WHO confirms the trial of anti-Malaria drug Hydroxychloroquine: The World Health Organization (WHO) has announced to resume the trials for anti-malaria drug Hydroxychloroquine for its effectiveness against the novel coronavirus.

Comments

Popular posts from this blog

Eurotech has carved its niche to address Networking and Communications requirements.

CLOUD COMPUTING : Nitin Hiranandani, Director, HP India

DCIM gaining momentum with growth of data centers